Assessment of severity and avoidability of adverse drug reactions in neonates: a reproducibility study of the Hartwig tool and LAAT
European Journal of Clinical Pharmacology · 2025
DOI: 10.1007/s00228-024-03765-8 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift European Journal of Clinical Pharmacology, 2025. Verfasst von Ramon Weyler Leopoldino und 6 weiteren Autor:innen. Beteiligte Einrichtung: Postgraduate Program in Pharmaceutical Sciences, Federal University of Rio Grande Do Norte (UFRN), Natal, RN, Brazil. Hauptthemen laut MEDLINE: Drug-Related Side Effects and Adverse Reactions, Intensive Care Units, Neonatal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Abstract (Originalsprache)
OBJECTIVE: Tools for classifying adverse drug reactions (ADRs) have not yet been validated in the context of the neonatal intensive care unit (NICU). The study aims to investigate the inter-rater reliability of the Hartwig tool and the Liverpool avoidability assessment tool (LAAT) in assessing the severity and avoidability of ADR cases in hospitalized neonates. METHODS: An observational and prospective study was conducted in the NICU of a maternity hospital in Natal, Brazil. The Hartwig tool and LAAT were employed to assess the severity and avoidability of ADRs, respectively. Three experienced clinical pharmacists independently assessed all ADR cases. Inter-rater reliability was measured using Cohen's kappa coefficient (k) with corresponding 95% confidence intervals (CI). RESULTS: Among 79 ADR cases, the mean gestational age was 29.7 ± 4.4 weeks, and the birth weight averaged 1446.0 ± 1179.3 g. The assessment of ADR severity using the Hartwig tool revealed a significant overall correlation (overall k = 0.573; 95% CI 0.395 to 0.753) with exact agreement (EA) and extreme disagreement (ED) rates between evaluators of 86.5% and 2.5%, respectively. However, no statistically significant correlation was observed for determining avoidability using the LAAT (overall k = 0.017; 95% CI - 0.048 to 0.082), with an EA rate of 83.6% and ED rate of 10.1%. CONCLUSION: The Hartwig tool demonstrates good reproducibility among different evaluators in determining the severity of ADRs, unlike the LAAT for assessing avoidability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Postgraduate Program in Pharmaceutical Sciences, Federal University of Rio Grande Do Norte (UFRN), Natal, RN, Brazil.
- Department of Pharmacy, UFRN, Natal, RN, Brazil.
- School Maternity Januário Cicco (MEJC/EBSERH), UFRN, Natal, RN, Brazil.
- Municipal Health Department of the City of Natal, Natal, RN, Brazil.
- Children's Hospital Varela Santiago, Natal, RN, Brazil.
- Postgraduate Program in Pharmaceutical Sciences, Federal University of Rio Grande Do Norte (UFRN), Natal, RN, Brazil. randrandall@gmail.com.
Förderung
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Zitieren
APA
Leopoldino, R. W., Rocha, L. C. A., Fernandes, F. E. M., de Lima Costa, H. T. M., Vale, L. M. P., Oliveira, A. G., & Martins, R. R. (2025). Assessment of severity and avoidability of adverse drug reactions in neonates: a reproducibility study of the Hartwig tool and LAAT. European Journal of Clinical Pharmacology. https://doi.org/10.1007/s00228-024-03765-8
Vancouver
Leopoldino RW, Rocha LCA, Fernandes FEM, de Lima Costa HTM, Vale LMP, Oliveira AG, et al. Assessment of severity and avoidability of adverse drug reactions in neonates: a reproducibility study of the Hartwig tool and LAAT. European Journal of Clinical Pharmacology. 2025. doi:10.1007/s00228-024-03765-8
BibTeX
@article{Leopoldino2025,
author = {Leopoldino, Ramon Weyler and Rocha, Luan Carvalho Assunção and Fernandes, Flávia Evelyn Medeiros and de Lima Costa, Haline Tereza Matias and Vale, Letícia Martins Pereira and Oliveira, Antonio Gouveia and Martins, Rand Randall},
title = {Assessment of severity and avoidability of adverse drug reactions in neonates: a reproducibility study of the Hartwig tool and LAAT},
journal = {European Journal of Clinical Pharmacology},
year = {2025},
doi = {10.1007/s00228-024-03765-8}
}
EUVIMED